| 3NV5 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | HEM, PEG | enzyme |
| ||||||||||||
| Gene | SARO | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | The structure of CYP101D2 unveils a potential path for substrate entry into the active site., Yang W, Bell SG, Wang H, Zhou W, Bartlam M, Wong LL, Rao Z, Biochem J. 2010 Oct 15. PMID:20950270 | ||||||||||||||
| Data retrieval |
![]() |
| View 3NV5 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |